Reata Pharmaceuticals (NASDAQ:RETA) reported its Q3 earnings results on Monday, November 8, 2021 at 08:00 AM.
Here’s what investors need to know about the announcement.
Earnings
Reata Pharmaceuticals their estimated earnings by 41.2%, reporting an EPS of $-1.27 versus an estimate of $-2.16, which surprised analysts.
Revenue was up $5,990,000 from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.76, which was followed by a 18.12% drop in the share price the next day.
Here’s a look at Reata Pharmaceuticals’s past performance:
| Quarter | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 |
|---|---|---|---|---|
| EPS Estimate | -2.08 | -2.10 | -2.16 | -1.98 |
| EPS Actual | -1.32 | -1.16 | -1.25 | -1.31 |
| Revenue Estimate | 1.25M | 1.19M | 1.44M | 1.27M |
| Revenue Actual | 2.22M | 944.00K | 3.19M | 1.40M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
